trial,pubID,pseudogroup,weeks,group,IgD-IgM-/IgA-/IgG+ B cells
G002,G002-931,G002,16,3,436077.0
G002,G002-997,G002,16,3,535771.0
G002,G002-852,G002,16,1,381355.0
G002,G002-616,G002,16,1,231618.0
G002,G002-678,G002,16,1,438408.0
G002,G002-884,G002,16,3,797539.0
G002,G002-796,G002,16,3,258349.0
G002,G002-595,G002,16,3,610412.0
G002,G002-988,G002,16,3,265061.0
G002,G002-905,G002,16,1,300904.0
G002,G002-632,G002,16,3,375648.0
G002,G002-619,G002,16,1,264406.0
G002,G002-546,G002,16,1,509832.0
G002,G002-304,G002,16,3,65928.0
G002,G002-477,G002,16,3,525684.0
G002,G002-371,G002,16,3,302417.0
G002,G002-866,G002,16,3,1077517.0
G002,G002-516,G002,16,1,384080.0
G002,G002-758,G002,16,1,99528.0
G002,G002-969,G002,16,1,653425.0
G002,G002-302,G002,16,1,351950.0
G002,G002-427,G002,16,3,416678.0
G002,G002-278,G002,16,3,165943.0
G002,G002-462,G002,16,3,306449.0
G002,G002-825,G002,16,3,102564.0
G002,G002-810,G002,16,3,229713.0
G002,G002-813,G002,16,1,27861.0
G002,G002-834,G002,16,1,11803.0
